| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |